The Importance of Measuring Executive Function When Studying the Effects of Cognition-Enhancing Agents

  1. Parminder Raina, PhD;
  2. Pasqualina L. Santaguida, PhD; and
  3. Christopher Patterson, MD
  1. From McMaster University, Hamilton L8S 4M1, Ontario, Canada.
    1. Figure.
      View larger version:
      Figure. Summary estimates for the change in Alzheimer's Disease Assessment Scale–cognitive subscale scores.

      The Figure includes Rockwood and colleagues' study (1) and the correction in Raskind and colleagues' study (3).

    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med September 2, 2008 vol. 149 no. 5 359-360
    1. ExcerptFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues